Zhang JX - Search Results

1

Diagnostic Accuracy of Fecal Calprotectin for Predicting Relapse in Inflammatory Bowel Disease: A Meta-Analysis.

Shi JT, Chen N, Xu J, Goyal H, Wu ZQ, Zhang JX, Xu HG. Shi JT, et al. Among authors: zhang jx. J Clin Med. 2023 Feb 2;12(3):1206. doi: 10.3390/jcm12031206. J Clin Med. 2023. PMID: 36769850 Free PMC article. Review.

2

Construction and validation of a prognostic model for kidney renal clear cell carcinoma based on podocyte-associated genes.

Chen C, Yang RX, Zhang JX, Xu HG. Chen C, et al. Among authors: zhang jx. Cancer Med. 2022 Oct;11(19):3549-3562. doi: 10.1002/cam4.4733. Epub 2022 Apr 4. Cancer Med. 2022. PMID: 35373928 Free PMC article.

3

5-Methylcytosine (m5C) Modification Patterns and Tumor Immune Infiltration Characteristics in Clear Cell Renal Cell Carcinoma.

Chen C, Chen LY, Zhang JX, Xu HG. Chen C, et al. Among authors: zhang jx. Curr Oncol. 2022 Dec 31;30(1):559-574. doi: 10.3390/curroncol30010044. Curr Oncol. 2022. PMID: 36661693 Free PMC article.

4

Identification of IRF-associated molecular subtypes in clear cell renal cell carcinoma to characterize immunological characteristics and guide therapy.

Chen C, Chen LY, Yang RX, Zhang JX, Shao PF, Xu HG. Chen C, et al. Among authors: zhang jx. Front Oncol. 2023 Jan 19;12:1118472. doi: 10.3389/fonc.2022.1118472. eCollection 2022. Front Oncol. 2023. PMID: 36741716 Free PMC article.

5

Beyond liver cancer, more application scenarios for alpha-fetoprotein in clinical practice.

Ma C, Jin Y, Wang Y, Xu H, Zhang J. Ma C, et al. Front Oncol. 2023 Sep 15;13:1231420. doi: 10.3389/fonc.2023.1231420. eCollection 2023. Front Oncol. 2023. PMID: 37781207 Free PMC article. Review.

6

[Correlation between methylation of interferon regulatory factor 6 gene promoter in renal tissues and overall survival of patients with Kidney renal clear cell carcinoma].

Zhang J, Chen C, Wei Y, Chen L, Shao P, Xu H. Zhang J, et al. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2024 Feb 10;41(2):150-156. doi: 10.3760/cma.j.cn511374-20220921-00635. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2024. PMID: 38311552 Chinese.

7

CD2AP is a potential prognostic biomarker of renal clear cell carcinoma.

Chen C, Xu J, Zhang JX, Chen LY, Wei YA, Zhang WM, Shao PF, Xu HG. Chen C, et al. Among authors: zhang wm, zhang jx. Cancer Med. 2024 Feb;13(4):e7055. doi: 10.1002/cam4.7055. Cancer Med. 2024. PMID: 38457255 Free PMC article.

8

Serum vitamin B12 levels during chemotherapy against diffuse large B-cell lymphoma: a case report and review of the literature.

Wang F, Wei L, Zhang B, Ling Z, Zhang J. Wang F, et al. Clin Chem Lab Med. 2024 Jun 12;62(12):e268-e270. doi: 10.1515/cclm-2024-0286. Print 2024 Nov 26. Clin Chem Lab Med. 2024. PMID: 38860928 Review. No abstract available.

9

Serum SP70 is a sensitive predictor of chemotherapy response in patients with advanced nonsmall cell lung cancer.

Liu J, Zhang W, Gu M, Ji Y, Yang L, Cheng X, Xiao X, Xu J, Gu C, Zhang J, Zhang S, Chen D, Pan S. Liu J, et al. Cancer Med. 2018 Jul;7(7):2925-2933. doi: 10.1002/cam4.1555. Epub 2018 May 16. Cancer Med. 2018. PMID: 29767438 Free PMC article.

10

Real-time monitoring efficiency and toxicity of chemotherapy in patients with advanced lung cancer.

Wang H, Zhang B, Chen D, Xia W, Zhang J, Wang F, Xu J, Zhang Y, Zhang M, Zhang L, Lu Y, Geng Y, Huang P, Huang P, Wang H, Pan S. Wang H, et al. Clin Epigenetics. 2015 Nov 5;7:119. doi: 10.1186/s13148-015-0150-9. eCollection 2015. Clin Epigenetics. 2015. PMID: 26550041 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,930 results

Search Page

Filters